These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38313183)
21. Research: Prevalence of neural tube defects Khartoum, Sudan August 2014-July 2015. Omer IM; Abdullah OM; Mohammed IN; Abbasher LA BMC Res Notes; 2016 Nov; 9(1):495. PubMed ID: 27881182 [TBL] [Abstract][Full Text] [Related]
22. PATTERNS OF NEURAL TUBE DEFECTS AT TWO TEACHING HOSPITALS IN ADDIS ABABA, ETHIOPIA A THREE YEARS RETROSPECTIVE STUDY. Sorri G; Mesfin E Ethiop Med J; 2015 Jul; 53(3):119-26. PubMed ID: 26677521 [TBL] [Abstract][Full Text] [Related]
23. Neural tube defects: is a decreasing prevalence associated with a decrease in severity? Cotter AM; Daly SF Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):161-3. PubMed ID: 15808372 [TBL] [Abstract][Full Text] [Related]
24. Periconceptional folic acid use prevents both rare and common neural tube defects in China. Zhou Y; Crider KS; Yeung LF; Rose CE; Li Z; Berry RJ; Li S; Moore CA Birth Defects Res; 2022 Mar; 114(5-6):184-196. PubMed ID: 35098705 [TBL] [Abstract][Full Text] [Related]
25. Folic acid and the decline in neural tube defects in Arkansas. Mosley BS; Hobbs CA; Flowers BS; Smith V; Robbins JM J Ark Med Soc; 2007 Apr; 103(10):247-50. PubMed ID: 17487022 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of neural tube defects in a rural area of north india from 2001 to 2014: A population-based survey. Kant S; Malhotra S; Singh AK; Haldar P; Kaur R; Misra P; Gupta N Birth Defects Res; 2017 Feb; 109(3):203-210. PubMed ID: 27875031 [TBL] [Abstract][Full Text] [Related]
27. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. Persad VL; Van den Hof MC; Dubé JM; Zimmer P CMAJ; 2002 Aug; 167(3):241-5. PubMed ID: 12186168 [TBL] [Abstract][Full Text] [Related]
28. High potential for reducing folic acid-preventable spina bifida and anencephaly, and related stillbirth and child mortality, in Ethiopia. Dixon M; Kancherla V; Magana T; Mulugeta A; Oakley GP Birth Defects Res; 2019 Nov; 111(19):1513-1519. PubMed ID: 31424635 [TBL] [Abstract][Full Text] [Related]
29. Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Blencowe H; Kancherla V; Moorthie S; Darlison MW; Modell B Ann N Y Acad Sci; 2018 Feb; 1414(1):31-46. PubMed ID: 29363759 [TBL] [Abstract][Full Text] [Related]
30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
31. Neural tube defects among neonates delivered in Al-Ramadi Maternity and Children's Hospital, western Iraq. Al-Ani ZR; Al-Hiali SJ; Al-Mehimdi SM Saudi Med J; 2010 Feb; 31(2):163-9. PubMed ID: 20174732 [TBL] [Abstract][Full Text] [Related]
32. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep; 1992 Sep; 41(RR-14):1-7. PubMed ID: 1522835 [TBL] [Abstract][Full Text] [Related]
33. Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy. Cavalli P; Tonni G; Grosso E; Poggiani C Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):962-5. PubMed ID: 21956977 [TBL] [Abstract][Full Text] [Related]
34. Prevalence and trend of neural tube defects in five counties in Shanxi province of Northern China, 2000 to 2014. Liu J; Zhang L; Li Z; Jin L; Zhang Y; Ye R; Liu J; Ren A Birth Defects Res A Clin Mol Teratol; 2016 Apr; 106(4):267-74. PubMed ID: 26879384 [TBL] [Abstract][Full Text] [Related]
35. Weekly administration of folic acid and epidemiology of neural tube defects. Martínez de Villarreal LE; Arredondo P; Hernández R; Villarreal JZ Matern Child Health J; 2006 Sep; 10(5):397-401. PubMed ID: 16900407 [TBL] [Abstract][Full Text] [Related]
36. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity. Feuchtbaum LB; Currier RJ; Riggle S; Roberson M; Lorey FW; Cunningham GC Genet Test; 1999; 3(3):265-72. PubMed ID: 10495925 [TBL] [Abstract][Full Text] [Related]
37. [Prevalence of neural tube defects in Asturias (Spain): impact of prenatal diagnosis]. García López E; Rodríguez Dehli C; Ariza Hevia F; Rodríguez Fernández A; Fernández Toral J; Riaño Galán I; Mosquera Tenreiro C Gac Sanit; 2009; 23(6):506-11. PubMed ID: 19406531 [TBL] [Abstract][Full Text] [Related]
38. Assessing the prevalence of spina bifida and encephalocele in a Kenyan hospital from 2005-2010: implications for a neural tube defects surveillance system. Githuku JN; Azofeifa A; Valencia D; Ao T; Hamner H; Amwayi S; Gura Z; Omolo J; Albright L; Guo J; Arvelo W Pan Afr Med J; 2014; 18():60. PubMed ID: 26113894 [TBL] [Abstract][Full Text] [Related]
39. Incidence of neural tube defects in Afyonkarahisar, Western Turkey. Onrat ST; Seyman H; Konuk M Genet Mol Res; 2009 Feb; 8(1):154-61. PubMed ID: 19283682 [TBL] [Abstract][Full Text] [Related]
40. Use of folic acid for prevention of spina bifida and other neural tube defects--1983-1991. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(30):513-6. PubMed ID: 2072886 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]